Tirofiban for cocaine-induced coronary artery thrombosis: a novel therapeutic approach.
Frangogiannis
N G
NG
Section of Cardiology, Department of Medicine, Baylor College of Medicine, and Ben Taub General Hospital, Houston, TX, USA.
Farmer
J A
JA
Lakkis
N M
NM
D000328:Adult; D003042:Cocaine / Q000009:adverse effects*; D003328:Coronary Thrombosis / Q000139:chemically induced / Q000188:drug therapy*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D000077466:Tirofiban; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014662:Vasoconstrictor Agents / Q000009:adverse effects*
D005343:Fibrinolytic Agents; D014662:Vasoconstrictor Agents; D014443:Tyrosine; D000077466:Tirofiban; D003042:Cocaine